Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells

Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells

US Patent 8318489 · Granted Nov 27, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inverted top-tier FET for multi-tier gate-on-gate 3-dimension integration (3Di)2025
Cardiomyocyte maturation2020
Differentiation and expansion of endothelial cells from pluripotent stem cells a2018
Cardiomyocyte differentiation2018
Differentiation of pluripotent stem cells with a kinase inhibitor or PGI22016
Differentiation of pluripotent stem cells with a kinase inhibitor or PGI22016
Differentiation of pluripotent stem cells with a kinase inhibitor or PGI22016
Direct differentiation of cardiomyocytes from embryonic stem cells2016
Direct differentiation of cardiomyocytes from embryonic stem cells2016
Direct differentiation of cardiomyocytes from embryonic stem cells2016
Direct differentiation of cardiomyocytes from embryonic stem cells2016
Direct differentiation of cardiomyocytes from embryonic stem cells2016